Uyku Bülteni

The purpose of the Sleep Bulletin is to contribute to the announcement and sharing of the researches related to sleep disorders by presenting them to the national and international scientific circles.

In the Journal of Sleep Bulletin; Clinical and experimental research, reviews, case reports, short article: short research articles and notes, letters to the editor, articles containing opinions, experiences and questions about the articles published in our journal, scientific summaries, scientific studies published in the international medical literature 100-150 Summarizing articles that summarize words, summarized books, and scientific studies can be published.

Sleep Bulletin is a journal published quarterly in March, June, September and December.
Sleep Bulletin is an international, scientific, open access, online/published journal in accordance with independent, unbiased, and double-blinded peer-review principles.
Sleep Bulletin publishes the researches in the fields of health sciences including clinical and experimental studies, reviews on current topics, case reports, editorial comments and letters to the editor and aimed to contribute the dissemination and sharing these articles with science world.
The journal’s publication language is Turkish and English.
There is no charge for publishing or no copyright fee is paid to the authors.
Sleep Bulletin has adopted the policy of providing open access with the publication.
Authors' credentials and e-mail addresses are in no way used for other purposes.
The editorial and publication processes of the journal are shaped in accordance with the guidelines of the International Council of Medical Journal Editors (ICMJE). The journal conforms to the Principles of Transparency and Best Practice in Scholarly Publishing (doaj.org/bestpractice).
Originality, high scientific quality and citation potential are the most important criteria for a manuscript to be accepted for publication. Manuscripts submitted for evaluation should not have been previously presented or already published in an electronic or printed medium. Manuscripts that have been presented in a meeting should be submitted with detailed information on the organization, including the name, date, and location of the organization.
An approval of research protocols by the Ethics Committee in accordance with international agreements (World Medical Association Declaration of Helsinki “Ethical Principles for Medical Research Involving Human Subjects,” amended in October 2013, www.wma.net) is required for experimental, clinical, and drug studies and for some case reports. If required, ethics committee reports or an equivalent official document will be requested from the authors.
• For manuscripts concerning experimental research on humans, a statement should be included that shows that written informed consent of patients and volunteers was obtained following a detailed explanation of the procedures that they may undergo.
• For studies carried out on animals, the measures taken to prevent pain and suffering of the animals should be stated clearly.
• Information on patient consent, the name of the ethics committee, and the ethics committee approval number should also be stated in the Materials and Methods section of the manuscript.
• It is the authors’ responsibility to carefully protect the patients’ anonymity. For photographs that may reveal the identity of the patients, releases signed by the patient or their legal representative should be enclosed.
All submissions are screened by a similarity detection software (iThenticate) and the limitation without similarity is 25%.
The Editorial Board of the journal handles all appeal and complaint cases within the scope of Committee on Publication Ethics (COPE) guidelines. In such cases, authors should get in direct contact with the editorial office regarding their appeals and complaints. When needed, an ombudsperson may be assigned to resolve cases that cannot be resolved internally. The Editor in Chief is the final authority in the decision-making process for all appeals and complaints.
When submitting a manuscript to Sleep Bulletin , authors accept to assign the copyright of their manuscript to the journal. If rejected for publication, the copyright of the manuscript will be assigned back to the authors. Sleep Bulletin requires each submission to be accompanied by a Copyright Transfer Form (available for download : https://dergipark.org.tr/en/pub/uykubulteni). When using previously published content, including figures, tables, or any other material in both print and electronic formats, authors must obtain permission from the copyright holder. Legal, financial and criminal liabilities in this regard belong to the author(s).
Statements or opinions expressed in the manuscripts published in Sleep Bulletin reflect the views of the author(s) and not the opinions of the editors, the editorial board, or the publisher; the editors, the editorial board, and the publisher disclaim any responsibility or liability for such materials. The final responsibility in regard to the published content rests with the authors.

MANUSCRIPT PREPARATION
Manuscripts can only be submitted through the journal’s online manuscript submission and evaluation system, available at : https://dergipark.org.tr/en/pub/uykubulteni. Manuscripts submitted via any other medium will not be evaluated.
Manuscripts submitted to the journal will first go through a technical evaluation process where the editorial office staff will ensure that the manuscript has been prepared and submitted in accordance with the journal’s guidelines. Submissions that do not conform to the journal’s guidelines will be returned to the submitting author with technical correction requests. The editor reserves the right to reject manuscripts that do not comply with the above-mentioned requirements. Corrections may be done without changing the main text.
Authors are required to submit the following:
• Copyright Transfer Form,
• Title Page (including Title of Manuscript, Running title, Author(s)’s name, title and institution, corresponder authour’s contact information, Name of the organization supporting the research)
• Main document (All articles should have an abstract before the main text).
• Figures (Jpeg format)
• Tables (max 6 table)

Preparation of the Main Document

The articles should be written with double-spaced in 12 pt, Times New Roman character and at least 2.5 cm from all edges of each page. The main text should not contain any information about the authors' names and affiliations.
Original articles should have a structured abstract. For case reports, the structured abstract is not used. Limit the abstract to 300 words. References, tables and citations should not be used in an abstract. Authors must include relevant keywords (3-5) on the line following the end of the abstract. For the international authors, submission of Turkish title, Turkish abstracts and Turkish keywords are not required. These will be provided by editorial office.
All acronyms and abbreviations used in the manuscript should be defined at first use, both in the abstract and in the main text. The abbreviation should be provided in parentheses following the definition.
When a drug, product, hardware, or software program is mentioned within the main text, product information, including the name of the product, the producer of the product, and city and the country of the company (including the state if in USA), should be provided in parentheses.
All references, tables, and figures should be referred to within the main text, and they should be numbered consecutively in the order they are referred to within the main text. The symbols used must be nomenclature used standards.

Original Research Articles should be maximum 4000 words and include subheadings below;
• Title (both in Turkish and English)
• Abstract (both in Turkish and English)
• Keywords (both in Turkish and English)
• Introduction
• Material and Methods
• Results
• Discussion
• Conclusions
• Figures and Tables Legend (if necessary)
• References
Case Reports should be maximum 2000 words and include subheadings below;
• Title (both in Turkish and English)
• Abstract (both in Turkish and English)
• Keywords (both in Turkish and English)
• Introduction
• Case Presentation
• Discussion and Conclusion
• Figures and Tables Legend (if necessary)
• References
Literature Reviews should be maximum 5000 words and include subheadings below;
• Title (both in Turkish and English)
• Abstract (both in Turkish and English)
• Keywords (both in Turkish and English)
• Main text
• Conclusion
• Figures and Tables Legend (if necessary)
• References
Letters to Editor should be maximum 1000 words and should include subheadings below;
• Title
• Keywords
• Main text
• Figures and Tables Legend (if necessary)
• References
Preparation of the Figures and Tables
Figures, graphics, and photographs should be submitted as separate files (in JPEG format) through the submission system.
• The files should not be embedded in a Word document or the main document.
• When there are figure subunits, the subunits should not be merged to form a single image. Each subunit should be submitted separately through the submission system.
• Images should be numbered by Arabic numbers to indicate figure subunits.
• The minimum resolution of each submitted figure should be 300 DPI.
• Figure legends should be listed at the end of the main document.
• Information or illustrations must not permit identification of patients, and written informed consent for publication must be sought for any photograph.

Tables should embedded in main document or should be submitted as separate files but if tables are submitted separately please note in where it is suitable in main text. Tables are limited with six tables. All tables should be numbered consecutively in the order they are used to within the main text. Tables legends should be listed at the end of the main document.

References
All references should be numbered consecutively in the order they are referred to within the main text in Vancouver style. If more than two consecutive resources are used, only the first and last source numbers should be specified, such as “(2-6)”.
Journal titles should be abbreviated in accordance with the journal abbreviations in Index Medicus. When there are 6 or fewer authors, all authors should be listed. If there are 7 or more authors, the first 6 authors should be listed followed by “et al.”
The reference styles for different types of publications are presented in the following examples;
For journals;
Neville K, Bromberg A, Bromberg S, Hanna BA,Rom WN. The third epidemic multidrug resistant tuberculosis. Chest 1994;1(4):45-8.
For books;
Sweetman SC. Martindale the Complete Drug Reference. 34th ed. London: Pharmaceutical Press; 2005.
For book section;
Collins P. Embryology and development, Neonatal anatomy and growth. In: Williams PL, Bannister LH, Berry MM, Collins P, Dyson M, Dussek JE, Ferguson MWJ. Gray's Anatomy (38th Ed) London, Churchill Livingstone, 1995; 91-342.
For website;
Gaudin S. How moon landing changed technology history [Internet]. Computerworld UK. 2009 [cited 15 June 2014]. Available from: http://www.computerworlduk.com/in-depth/it-business/2387/how-moon-landing-changed-technology-history/
For conference proceeding;
Proceedings of the Symposium on Robotics, Mechatronics and Animatronics in the Creative and Entertainment Industries and Arts. SSAISB 2005 Convention. University of Hertfordshire, Hatfield, UK; 2005.
For Thesis;
Ercan S. Venöz yetmezlikli hastalarda kalf kası egzersizlerinin venöz fonksiyona ve kas gücüne etkisi. Suleyman Demirel University Faculty of Medicine Sports Medicine Department Thesis. Isparta: Suleyman Demirel University. 2016.

Retraction or Reject
Manuscipt Retraction: For any other reason authors may withdraw their manuscript from the journal with a written declaration.
Manusript Reject: The manusripts which are not accepted to be published are rejected with explanations
AFTER ACCEPTANCE
If the manuscript is accepted, the acceptance letter is sentwithin two weeks, the last version of manuscript is sent to author fort the last corresponding. The journal owner and the editorial board are authorized to decide in which volume of the accepted article will be printed.
Authors may publish their articles on their personal or corporate websites by linking them to the appropraite cite and library rules.

An approval of research protocols by the Ethics Committee in accordance with international agreements (World Medical Association Declaration of Helsinki “Ethical Principles for Medical Research Involving Human Subjects,” amended in October 2013, www.wma.net) is required for experimental, clinical, and drug studies and for some case reports. If required, ethics committee reports or an equivalent official document will be requested from the authors.
• For manuscripts concerning experimental research on humans, a statement should be included that shows that written informed consent of patients and volunteers was obtained following a detailed explanation of the procedures that they may undergo.
• For studies carried out on animals, the measures taken to prevent pain and suffering of the animals should be stated clearly.
• Information on patient consent, the name of the ethics committee, and the ethics committee approval number should also be stated in the Materials and Methods section of the manuscript.
• It is the authors’ responsibility to carefully protect the patients’ anonymity. For photographs that may reveal the identity of the patients, releases signed by the patient or their legal representative should be enclosed.
All submissions are screened by a similarity detection software (iThenticate) and the limitation without similarity is 25%.
The Editorial Board of the journal handles all appeal and complaint cases within the scope of Committee on Publication Ethics (COPE) guidelines. In such cases, authors should get in direct contact with the editorial office regarding their appeals and complaints. When needed, an ombudsperson may be assigned to resolve cases that cannot be resolved internally. The Editor in Chief is the final authority in the decision-making process for all appeals and complaints.